XML 23 R1.htm IDEA: XBRL DOCUMENT v3.26.1
Cover - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Mar. 12, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2025    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2025    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41952    
Entity Registrant Name Telomir Pharmaceuticals, Inc.    
Entity Central Index Key 0001971532    
Entity Tax Identification Number 85-3354547    
Entity Incorporation, State or Country Code FL    
Entity Address, Address Line One 100 SE 2nd St    
Entity Address, Address Line Two Suite 200 #1009    
Entity Address, City or Town Miami    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33131    
City Area Code 786    
Local Phone Number 396-6723    
Title of 12(b) Security Common stock, no par value    
Trading Symbol TELO    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 18.1
Entity Common Stock, Shares Outstanding   34,380,971  
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction [Flag] false    
Auditor Firm ID 106    
Auditor Name SALBERG & COMPANY, P.A.    
Auditor Location Boca Raton, Florida